Gene-specific recruitment of positive and negative elongation factors during stimulated transcription of the MKP-1 gene in neuroendocrine cells

Nucleic Acids Research

Volumn 35, Issue 3, 2007, Pages 1007-1017

  Fujita, Toshitsugu ^a   Ryser, Stephan ^a   Tortola, Silvia ^b   Piuz, Isabelle ^a   Schlegel, Werner ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; 5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE SENSITIVITY INDUCING FACTOR; ELONGATION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NEGATIVE ELONGATION FACTOR; POSITIVE ELONGATION FACTOR B; PROTIRELIN; RNA POLYMERASE II; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HYPOPHYSIS CELL; INHIBITION KINETICS; MAMMAL CELL; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REGULATORY MECHANISM;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE 9; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMEDIATE-EARLY PROTEINS; MODELS, GENETIC; PHOSPHOPROTEIN PHOSPHATASE; PITUITARY GLAND; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RNA POLYMERASE II; SERINE; THYROTROPIN-RELEASING HORMONE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ELONGATION FACTORS;

MAMMALIA;

EID: 33847381502     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl1138     Document Type: Article

References (58)

1. Camps,M., Nichols,A. and Arkinstall,S. (1999) Dual specificity phosphatases: A gene family for control of MAP kinase function. FASEB J., 14, 6-16.
2. Bueno,O.F., De Windt,L.J., Lim,H.W., Tymitz,K.M., Witt,S.A., Kimball,T.R. and Molkentin,J.D. (2001) The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ. Res., 88, 88-96.
3. Grimshaw,M.J. and Baikwill,F.R. (2001) Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation-a potential mechanism. Eur. J. Immunol., 31, 480-489.
4. Wang,H.Y., Cheng,Z. and Malbon,C.C. (2003) Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett., 191, 229-237.
5. Leav,I., Galluzzi,C.M., Ziar,J., Stork,P.J., Ho,S.M. and Loda,M. (1996) Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. Lab. Invest., 75, 361-370.
6. Loda,M., Capodieci,P., Mishra,R., Yao,H., Corless,C., Grigioni,W., Wang,Y., Magi-Galluzzi,C. and Stork,P.J. (1996) Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am. J. Pathol., 149, 1553-1564.
7. Magi-Galluzzi,C., Mishra,R., Fiorentino,M., Montironi,R., Yao,H., Capodieci,P., Wishnow,K., Kaplan,I., Stork,P.J. and Loda,M. (1997) Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab. Invest., 76, 37-51.
8. Magi-Galluzzi,C., Montironi,R., Cangi,M.G., Wishnow,K. and Loda,M. (1998) Mitogen-activated protein kinases and apoptosis in PIN. Virchows Arch., 432, 407-413.
9. Charles,C.H., Abler,A.S. and Lau,L.F. (1992) cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene, 7, 187-190.
10. Keyse,S.M. and Emslie,E.A. (1992) Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature, 359, 644-647.
11. Kwak,S.P., Hakes,D.J., Martell,K.J. and Dixon,J.E. (1994) Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J. Biol. Chem., 269, 3596-3604.
12. Guo,Y.L., Kang,B. and Williamson,J.R. (1998) Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem., 273, 10362-10366.
13. Laderoute,K.R., Mendonca,H.L., Calaoagan,J.M., Knapp,A.M., Giaccia,A.J. and Stork,P.J. (1999) Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J. Biol. Chem., 274, 12890-12897.
14. Sommer,A., Burkhardt,H., Keyse,S.M. and Luscher,B. (2000) Synergistic activation of the mkp-1 gene by protein kinase A signaling and USF, but not c-Myc. FEBS Lett., 474, 146-150.
15. Kassel,O., Sancono,A., Kratzschmar,J., Kreft,B., Stassen,M. and Cato,A.C. (2001) Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J., 20, 7108-7116.
16. Xu,Q., Konta,T., Furusu,A., Nakayama,K., Lucio-Cazana,J., Fine,L.G. and Kitamura,M. (2002) Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J. Biol. Chem., 277, 41693-41700.
17. Ryser,S., Massiha,A., Piuz,I. and Schlegel,W. (2004) Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter. Biochem. J., 378, 473-484.
18. Ryser,S., Tortola,S., van Haasteren,G., Muda,M., Li,S. and Schlegel,W. (2001) MAP kinase phosphatase-1 gene transcription in rat neuroendocrine cells is modulated by a calcium-sensitive block to elongation in the first exon. J. Biol. Chem., 276, 33319-33327.
19. Krumm,A., Meulia,T. and Groudine,M. (1993) Common mechanisms for the control of eukaryotic transcriptional elongation. Bioessays, 15, 659-665.
20. Proudfoot,N.J., Furger,A. and Dye,M.J. (2002) Integrating mRNA processing with transcription. Cell, 108, 501-512.
21. Conaway,J.W., Shilatifard,A., Dvir,A. and Conaway,R.C. (2000) Control of elongation by RNA polymerase II. Trends Biochem. Sci., 25, 375-380.
22. Kobor,M.S. and Greenblatt,J. (2002) Regulation of transcription elongation by phosphorylation. Biochim. Biophys. Acta., 1577, 261-275.
23. Palancade,B. and Bensaude,O. (2003) Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur. J. Biochem., 270, 3859-3870.
24. Meinhart,A., Kamenski,T., Hoeppner,S., Baumli,S. and Cramer,P.A. (2005) A structural perspective of CTD function. Genes Dev., 19, 1401-1415.
25. Wada,T., Takagi,T., Yamaguchi,Y., Ferdous,A., Imai,T., Hirose,S., Sugimoto,S., Yano,K., Hartzog,G.A. et al. (1998) DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev., 12, 343-356.
26. Wada,T., Takagi,T., Yamaguchi,Y., Watanabe,D. and Handa,H. (1998) Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J., 17, 7395-7403.
27. Yamaguchi,Y., Wada,T. and Handa,H. (1998) Interplay between positive and negative elongation factors: Drawing a new view of DRB. Genes Cells, 3, 9-15.
28. Yamaguchi,Y., Takagi,T., Wada,T., Yano,K., Furuya,A., Sugimoto,S., Hasegawa,J. and Handa,H. (1999) NELF, a multi-subunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell, 97, 41-51.
29. Yamaguchi,Y., Inukai,N., Narita,T., Wada,T. and Handa,H. (2002) Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol. Cell. Biol., 22, 2918-2927.
30. Narita,T., Yamaguchi,Y., Yano,K., Sugimoto,S., Chanarat,S., Wada,T., Kim,D.K., Hasegawa,J., Omori,M. et al. (2003) Human transcription elongation factor NELF: Identification of novel subunits and reconstitution of the functionally active complex. Mol. Cell. Biol., 23, 1863-1873.
31. Andrulis,E.D., Guzman,E., Doring,P., Werner,J. and Lis,J.T. (2000) High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: Roles in promoter proximal pausing and transcription elongation. Genes Dev., 14, 2635-2649.
32. Boehm,A.K., Saunders,A., Werner,J. and Lis,J.T. (2003) Transcription factor and polymerase recruitment, modification, and movement on dhsp70 in vivo in the minutes following heat shock. Mol. Cell. Biol., 23, 7628-7637.
33. Wu,C.H., Yamaguchi,Y., Benjamin,L.R., Horvat-Gordon,M., Washinsky,J., Enerly,E., Larsson,J., Lambertsson,A., Handa,H. et al. (2003) NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev., 17, 1402-1414.
34. Gomes,N.P., Bjerke,G., Llorente,B., Szostek,S.A., Emerson,B.M. and Espinosa,J.M. (2006) Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev., 20, 601-612.
35. Aida,M., Chen,Y., Nakajima,K., Yamaguchi,Y., Wada,T. and Handa,H. (2006) Transcriptional pausing caused by NELF plays a dual role in regulating immediate-early expression of the junB gene. Mol. Cell. Biol., 26, 6094-6104.
36. Yamada,T., Yamaguchi,Y., Inukai,N., Okamoto,S., Mura,T. and Handa,H. (2006) P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Mol. Cell, 21, 227-237.
37. Wuarin,J. and Schibler,U. (1994) Physical isolation of nascent RNA chains transcribed by RNA polymerase II: Evidence for cotranscriptional splicing. Mol. Cell. Biol., 14, 7219-7225.
38. Marshall,N.F., Peng,J., Xie,Z. and Price,D.H. (1996) Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem., 271, 27176-27183.
39. Ivanov,D., Kwak,Y.T., Guo,J. and Gaynor,R.B. (2000) Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol., 20, 2970-2983.
40. Komarnitsky,P., Cho,E.J. and Buratowski,S. (2000) Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev., 14, 2452-2460.
41. Zhou,M., Halanski,M.A., Radonovich,M.F., Kashanchi,F., Peng,J., Price,D.H. and Brady,J.N. (2000) Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol., 20, 5077-5086.
42. Lavoie,S.B., Albert,A.L., Handa,H., Vincent,M. and Bensaude,O. (2001) The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J. Mol. Biol., 312, 675-685.
43. Ramanathan,Y., Rajpara,S.M., Reza,S.M., Lees,E., Shuman,S., Mathews,M.B. and Pe'ery,T. (2001) Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J. Biol. Chem., 276, 10913-10929.
44. Kim,Y:K., Bourgeois,C.F., Isel,C., Churcher,M.J. and Karn,J. (2002) Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol. Cell. Biol., 22, 4622-4637.
45. Shim,E.Y., Walker,A.K., Shi,Y. and Blackwell,T.K. (2002) CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes Dev., 16, 2135-2146.
46. Ryser,S., Tortola,S. and Schlegel,W. (2002) Map kinase phosphatase-1 gene expression and regulation in neuroendocrine cells. J. Recept. Signal Transduct. Res., 22, 17-29.
47. Swanson,M.S., Malone,E.A. and Winston,F. (1991) SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. Mol. Cell Biol., 11, 3009-3019.
48. Malone,E.A., Fassler,J.S. and Winston,F. (1993) Molecular and genetic characterization of SPT4, a gene important for transcription initiation in Saccharomyces cerevisiae. Mol. Gen. Genet., 237, 449-459.
49. Compagnone-Post,P.A. and Osley,M.A. (1996) Mutations in the SPT4, SPT5, and SPT6 genes alter transcription of a subset of histone genes in Saccharomyces cerevisiae. Genetics, 143, 1543-1554.
50. Rondon,A.G., Garcia-Rubio,M., Gonzalez-Barrera,S. and Aguilera,A. (2003) Molecular evidence for a positive role of Spt4 in transcription elongation. EMBO J., 22, 612-620.
51. Cui,Y. and Denis,C.L. (2003) In vivo evidence that defects in the transcriptional elongation factors RPB2, TFIIS, and SPT5 enhance upstream poly(A) site utilization. Mol. Cell. Biol., 23, 7887-7901.
52. Lindstrom,D.L., Squazzo,S.L., Muster,N., Burckin,T.A., Wachter,K.C., Emigh,C.A., McCleery,J.A., Yates,J.R.III and Hartzog,G.A. (2003) Dual roles for Spt5 in pre-mRNA processing and transcription elongation revealed by identification of Spt5-associated proteins. Mol. Cell. Biol., 23, 1368-1378.
53. Bourgeois,C.F., Kim,Y.K., Churcher,M.J., West,M.J. and Karn,J. (2002) Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences. Mol. Cell. Biol., 22, 1079-1093.
54. Fujinaga,K., Irwin,D., Huang,Y., Taube,R., Kurosu,T. and Peterlin,B.M. (2004) Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol., 24, 787-795.
55. Buratowski,S. (2003) The CTD code. Nat. Struct. Biol., 10, 679-680.
56. Peterlin,B.M. and Price,D.H. (2006) Controlling the elongation phase of transcription with P-TEFb. Mol. Cell, 23, 297-305.
57. Barboric,M., Nissen,R.M., Kanazawa,S., Jabrane-Ferrat,N. and Peterlin,B.M. (2001) NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell, 8, 327-337.
58. Aiyar,S.E., Sun,J.L., Blair,A.L., Moskaluk,C.A., Lu,Y.Z., Ye,Q.N., Yamaguchi,Y., Mukherjee,A., Ren,D.M. et al. (2004) Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev., 18, 2134-2146.